Please login to the form below

Not currently logged in
Email:
Password:

Ex J&J VP joins board of Immune

Cameron Durrant also has senior experience at Pharmacia
cameron durrant immune

Immune Pharmaceuticals has added veteran pharma experience to its board with the appointment of Cameron Durrant.

Immune will benefit from Durrant's knowledged of the iundstry gained during time in roles such as worldwide VP at Johnson & Johnson and VP, Pharmacia until its acquisition by Pfizer.

His other experience includes serving as CEO of PediatRx and CEO of PediaMed Pharmaceuticals as part of a career in pharma that began at Merck & Co.

Dr Daniel Teper, Immune's chairman and CEO, commented: "I have been privileged to work with Cameron in several of his leadership roles at GSK, Pharmacia, J&J and PediaMed.

“His entrepreneurial drive along with the discipline acquired at leading companies and his extensive board experience at public and private companies will be a strong asset as Immune expands its clinical development and commercialisation activities."

Immune specialises in developing antibodies to treat patients with inflammatory diseases and cancer. Its lead product candidate is bertilimumab, which is in clinical development for ulcerative colitis and Crohn's Disease as well as the rare skin condition bullous pemphigoid.

21st July 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics